scholarly journals Aging-associated immune system changes in multiple myeloma: the dark side of the moon.

Author(s):  
Alissa Visram ◽  
Taxiarchis V. Kourelis
2007 ◽  
Vol 31 (8) ◽  
pp. 1153-1155 ◽  
Author(s):  
Ridvan Ali ◽  
Fahir Ozkalemkas ◽  
Atilla Ozkan ◽  
Vildan Ozkocaman ◽  
Tulay Ozcelik ◽  
...  

2018 ◽  
Author(s):  
Paul Enck ◽  
Sibylle Klosterhalfen
Keyword(s):  
The Moon ◽  

2020 ◽  
Vol 13 (12) ◽  
pp. 451
Author(s):  
Elena Zamagni ◽  
Paola Tacchetti ◽  
Paola Deias ◽  
Francesca Patriarca

The recent introduction of monoclonal antibodies (MoAbs), with several cellular targets, such as CD-38 (daratumumab and isatuximab) and SLAM F7 (elotuzumab), differently combined with other classes of agents, has significantly extended the outcomes of patients with multiple myeloma (MM) in different phases of the disease. Initially used in advanced/refractory patients, different MoAbs combination have been introduced in the treatment of newly diagnosed transplant eligible patients (NDTEMM), showing a significant improvement in the depth of the response and in survival outcomes, without a significant price in terms of toxicity. In smoldering MM, MoAbs have been applied, either alone or in combination with other drugs, with the goal of delaying the progression to active MM and restoring the immune system. In this review, we will focus on the main results achieved so far and on the main on-going trials using MoAbs in SMM and NDTEMM.


2021 ◽  
Vol 45 (1) ◽  
Author(s):  
Padmalochan Hembram

Abstract Background Coronavirus disease 19 is a viral infection caused by a novel coronavirus, SARS-CoV-2. It was first notified in Wuhan, China, is now spread into numerous part of the world. Thus, the world needs urgent support and encouragement to develop a vaccine or antiviral treatments to combat the atrocious outbreak. Main body of the abstract The origin of this virus is yet unknown; however, rapid transmission from human-to-human “Anthroponosis” has widely confirmed. The world is witnessing a continuous hike in SARS-CoV-2 infection. In light of the outbreak of coronavirus disease 19, we have aimed to highlight the basic and vital information about the novel coronavirus. We provide an overview of SARS-CoV-2 transmission, timeline and its pathophysiological properties which would be an aid for the development of therapeutic molecules and antiviral drugs. Immune system plays a crucial role in virus infection in order to control but may have dark side when becomes uncontrollable. The host and SARS-CoV-2 interaction describe how the virus exploits host machinery and how overactive host immune response can cause disease severity also addressed in this review. Short conclusion Safe and effective vaccines may be the game-changing tools, but in the near future wearing mask, washing hands at regular intervals, avoiding crowed, maintaining physical distancing and hygienic surrounding, must be good practices to reduce and break the transmission chain. Still, research is ongoing not only on how vaccines protect against disease, but also against infection and transmission.


1984 ◽  
Vol 37 (3) ◽  
pp. 428
Author(s):  
Kate Jennings
Keyword(s):  

2016 ◽  
Vol 43 (8) ◽  
pp. 1491-1492
Author(s):  
Raffaele Giubbini ◽  
Francesco Bertagna

2021 ◽  
Vol 96 ◽  
pp. 102190
Author(s):  
Cecilia Becattini ◽  
Marcello Di Nisio ◽  
Laura Franco ◽  
Agnes Lee ◽  
Giancarlo Agnelli ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document